Dysregulated APP expression and α-secretase processing of APP is involved in manganese-induced cognitive impairment

Yiping Yang1, Jie Zhang2, Xiaobo Yang3

  • 1Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning 530021, Guangxi, China.

Insights

Manganese (Mn) exposure impairs cognition by reducing amyloid precursor protein (APP) and alpha-secretase activity, impacting synapse proteins. This suggests targeting APP processing may help treat Mn-induced neurotoxicity.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Excessive manganese (Mn) exposure is linked to cognitive impairment, resembling Alzheimer's disease (AD) symptoms.
  • The precise mechanisms underlying Mn-induced cognitive deficits, particularly involving amyloid precursor protein (APP) processing, are not fully understood.

Purpose of the Study:

  • To investigate the role of APP and its secretase processing in manganese-induced cognitive impairment.
  • To elucidate the molecular mechanisms by which Mn exposure affects APP metabolism and synaptic function.

Main Methods:

  • Established in vivo (mouse model) and in vitro (Neuro-2a cells) systems to study Mn neurotoxicity.
  • Utilized APP overexpression and knockdown cell models to assess the impact of APP levels on Mn effects.
  • Measured cognitive function, protein expression (APP, secretases, synapse proteins), and enzyme activities.

Main Results:

  • Mn exposure impaired cognitive function in mice.
  • Mn inhibited the expression and activity of APP and alpha-secretase, reducing soluble APP alpha protein (sAPPα) and synapse proteins.
  • Mn did not affect beta-secretase activity or levels of Aβ40 and Aβ42.

Conclusions:

  • APP and its alpha-secretase processing play a critical role in manganese-induced cognitive impairment.
  • Targeting APP alpha-secretase pathway may offer a therapeutic strategy for mitigating Mn neurotoxicity and cognitive deficits.